background
background
GILD
Gilead Sciences Inc
$110.08
-1.03
-0.93%
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down

Gilead Sciences Beat Expectations

Thursday, April 24, 2025 at 4:02 PM ET

Gilead Sciences (GILD) reported earnings of $1.81 per share on revenue of $6.67 billion for the first quarter ended March 2025. The consensus earnings estimate was $1.82 per share on revenue of $6.79 billion. The Earnings Whisper number was $1.79 per share. The company beat expectations by 1.12% while revenue fell 0.28% compared to the same quarter a year ago.

The company said it continues to expect 2025 earnings of $7.70 to $8.10 per share on revenue of $28.20 billion to $28.60 billion. The current consensus earnings estimate is $7.92 per share on revenue of $28.66 billion for the year ending December 31, 2025.

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Earnings Whisper Grade
Earnings Whisper GradeEarningsWhisper®edarG-
Power Rating
-
Reported Earnings
$1.81
Earnings Whisper®
$1.79
Consensus Estimate
$1.82
Earnings Surprise
1.1%
Earnings Growth
237.1%
Reported Revenue
$6.67 Bil
Revenue Estimate
$6.79 Bil
Revenue Surprise
-1.8%
Revenue Growth
-0.3%